Taysha Gene Therapies Inc (NAS:TSHA)
$ 2.065 -0.085 (-3.95%) Market Cap: 415.85 Mil Enterprise Value: 365.67 Mil PE Ratio: 0 PB Ratio: 7.12 GF Score: 31/100

Taysha Gene Therapies Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript

Release Date Price: $6.34 (-2.76%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot